Skip to content
Screener

Aquestive Therapeutics, Inc. AQST Q2 2026 earnings

Reported August 11, 2026 · After market close

Revenue$13.8MBeat by $2.4M
EPS-$0.18Miss by $0.08
Revenue estimate$11.4M
EPS estimate-$0.11

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$11.0M
EPS estimate-$0.10

Financials

Q2 2026

Income statement

See full
Revenue$13.8M+38.1%
Gross profit$9.8M+80.1%
Operating income-$8.2M+27.7%
Net income-$22.9M-68.8%
EPS (diluted)-$0.18-28.6%

Balance sheet

See full
Cash & equivalents$98.5M+62.7%
Total debt$63.4M+6.0%
Total equity-$56.6M+22.0%
Total assets$132.1M+41.0%

Cash flow

See full
Operating cash flow-$9.4M-19.3%
CapEx$212.0K+98.1%
Free cash flow-$9.7M-20.3%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$603.71M+3.5%
Enterprise value$568.6M-2.3%
P/S11.2×-2.1×

Profitability

See full
Gross margin67%+5.9pp
Operating margin-97.5%-15.0pp
Net margin-144.6%-2.6pp
FCF margin-85%-17.0pp

Returns & leverage

See full
Current ratio7.2×+3.7×

Segments

By product

See full
Manufacture and supply revenue$11.9M+24.3%
License and royalty revenue (a)$1.3M+58.0%
Co-development and research fees$582.0K+54.0%
Proprietary product revenue, net-—

By segment

See full
Reportable Segment$13.8M+38.1%

FAQ

When did Aquestive Therapeutics, Inc. report Q2 2026 earnings?
Aquestive Therapeutics, Inc. (AQST) reported Q2 2026 earnings on August 11, 2026 after market close.
What were Aquestive Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Aquestive Therapeutics, Inc. reported revenue of $13.8M and eps of $-0.18 for Q2 2026.
Did Aquestive Therapeutics, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $11.4M by $2.4M. EPS missed the consensus estimate of $-0.10 by $0.07.
How did Aquestive Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 38.1% from $10.0M a year earlier and eps declined 28.6% from $-0.14.
Where can I find Aquestive Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001398733-26-000035) and the 10-Q periodic report (0001398733-26-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.